10.2(top 1%)
impact factor
3.1K(top 10%)
papers
161.6K(top 5%)
citations
172(top 2%)
h-index
10.4(top 2%)
impact factor
3.8K
all documents
170.6K
doc citations
262(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1PI3K/Akt signalling pathway and cancerCancer Treatment Reviews20041,918
2Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews20011,651
3Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews20071,338
4The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancerCancer Treatment Reviews20131,051
5Osteosarcoma treatment – Where do we stand? A state of the art reviewCancer Treatment Reviews20141,028
6CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapyCancer Treatment Reviews2018867
7Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewCancer Treatment Reviews2008832
8Elevated copper and oxidative stress in cancer cells as a target for cancer treatmentCancer Treatment Reviews2009801
9Epidemiology of childhood cancerCancer Treatment Reviews2010769
10New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and BaicalinCancer Treatment Reviews2009740
11Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitorsCancer Treatment Reviews2018730
12Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trialsCancer Treatment Reviews1997717
13Management of toxicities of immune checkpoint inhibitorsCancer Treatment Reviews2016706
14Interleukin-6 signaling pathway in targeted therapy for cancerCancer Treatment Reviews2012585
15Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlookCancer Treatment Reviews2020573
16Primary bone osteosarcoma in the pediatric age: State of the artCancer Treatment Reviews2006562
17The management of brain metastasesCancer Treatment Reviews2003560
18Cellular pH regulators: potentially promising molecular targets for cancer chemotherapyCancer Treatment Reviews2003554
19Leptomeningeal carcinomatosisCancer Treatment Reviews1999491
20Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapiesCancer Treatment Reviews2003484
21The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevantCancer Treatment Reviews2015482
22Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporationCancer Treatment Reviews2003481
23The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting AgentsCancer Treatment Reviews2011480
24The proteasome: structure, function, and role in the cellCancer Treatment Reviews2003472
25Molecular biology in breast cancer: Intrinsic subtypes and signaling pathwaysCancer Treatment Reviews2012466
26Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolizationCancer Treatment Reviews2011460
27Tolerability and safety of rituximab (MabThera®)Cancer Treatment Reviews2005442
28Clinical pharmacokinetics of tyrosine kinase inhibitorsCancer Treatment Reviews2009437
29Resistance to PD1/PDL1 checkpoint inhibitionCancer Treatment Reviews2017437
30The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literatureCancer Treatment Reviews2016432
31Mitomycin C: a reviewCancer Treatment Reviews1976430
32Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensusCancer Treatment Reviews2015430
33Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the futureCancer Treatment Reviews2015414
34Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivativesCancer Treatment Reviews2012408
35Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews1979398
36Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTsCancer Treatment Reviews2017398
37Sarcoid reactions in malignant tumoursCancer Treatment Reviews1986394
38Molecular targeted therapy of glioblastomaCancer Treatment Reviews2019386
39Multi-functional nanocarriers to overcome tumor drug resistanceCancer Treatment Reviews2008381
40Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapyCancer Treatment Reviews1998380
41Evolving role of uPA/uPAR system in human cancersCancer Treatment Reviews2008371
42Epithelial cell adhesion molecule expression (CD326) in cancer: A short reviewCancer Treatment Reviews2012363
43Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapyCancer Treatment Reviews2015358
44Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews1976356
45Targeting CDK4/6 in patients with cancerCancer Treatment Reviews2016356
46Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapyCancer Treatment Reviews2016354
47The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targetsCancer Treatment Reviews2014350
48Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic reviewCancer Treatment Reviews2012349
49Long-term outcome of laparoscopic surgery for colorectal cancer: A cochrane systematic review of randomised controlled trialsCancer Treatment Reviews2008346
50Survivin: A new target for anti-cancer therapyCancer Treatment Reviews2009346